4.6 Article

Isoform-specific functions of phosphoinositide 3-kinases:: p110δ but not p110γ promotes optimal allergic responses in vivo

Journal

JOURNAL OF IMMUNOLOGY
Volume 180, Issue 4, Pages 2538-2544

Publisher

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.180.4.2538

Keywords

-

Categories

Funding

  1. Biotechnology and Biological Sciences Research Council [BB/C505659/2, BB/C505659/1] Funding Source: researchfish
  2. Biotechnology and Biological Sciences Research Council [BB/C505659/1, BB/C505659/2] Funding Source: Medline

Ask authors/readers for more resources

The leukocyte-enriched p110 gamma and p110 delta isoforms of PI3K have been shown to control in vitro degranulation of mast cells induced by cross-linking of the high affinity receptor of IgE (Fc epsilon RI). However, the relative contribution of these PI3K isoforms in IgE-dependent allergic responses in vivo is controversial. A side-by-side comparative analysis of the role of p110 gamma and p110 delta in mast cell function, using genetic approaches and newly developed isoform-selective pharmacologic inhibitors, confirms that both PI3K isoforms play an important role in Fc epsilon RI-activated mast cell degranulation in vitro. In vivo, however, only p110 delta was found to be required for optimal IgE/Ag-dependent hypersensitivity responses in mice. These observations identify p110 delta as a key therapeutic target among PI3K isoforms for allergy- and mast cell-related diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and Sensitivity

Samira Alliouachene, Benoit Bilanges, Gaetan Chicanne, Karen E. Anderson, Wayne Pearce, Khaled Ali, Colin Valet, York Posor, Pei Ching Low, Claire Chaussade, Cheryl L. Scudamore, Rachel S. Salamon, Jonathan M. Backer, Len Stephens, Phill T. Hawkins, Bernard Payrastre, Bart Vanhaesebroeck

CELL REPORTS (2015)

Article Genetics & Heredity

Novel Role for p110β PI 3-Kinase in Male Fertility through Regulation of Androgen Receptor Activity in Sertoli Cells

Julie Guillermet-Guibert, Lee B. Smith, Guillaume Halet, Maria A. Whitehead, Wayne Pearce, Diane Rebourcet, Kelly Leon, Pascale Crepieux, Gemma Nock, Maria Stromstedt, Malin Enerback, Claude Chelala, Mariona Graupera, John Carroll, Sabina Cosulich, Philippa T. K. Saunders, Ilpo Huhtaniemi, Bart Vanhaesebroeck

PLOS GENETICS (2015)

Article Endocrinology & Metabolism

Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice

Samira Alliouachene, Benoit Bilanges, Claire Chaussade, Wayne Pearce, Lazaros C. Foukas, Cheryl L. Scudamore, Larissa S. Moniz, Bart Vanhaesebroeck

DIABETOLOGIA (2016)

Article Cell Biology

Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans

Sandra D. Castillo, Elena Tzouanacou, May Zaw-Thin, Inma M. Berenjeno, Victoria E. R. Parker, Inigo Chivite, Maria Mila-Guasch, Wayne Pearce, Isabelle Solomon, Ana Angulo-Urarte, Ana M. Figueiredo, Robert E. Dewhurst, Rachel G. Knox, Graeme R. Clark, Cheryl L. Scudamore, Adam Badar, Tammy L. Kalber, Julie Foster, Daniel J. Stuckey, Anna L. David, Wayne A. Phillips, Mark F. Lythgoe, Valerie Wilson, Robert K. Semple, Neil J. Sebire, Veronica A. Kinsler, Mariona Graupera, Bart Vanhaesebroeck

SCIENCE TRANSLATIONAL MEDICINE (2016)

Article Multidisciplinary Sciences

Vps34 PI 3-kinase inactivation enhances insulin sensitivity through reprogramming of mitochondrial metabolism

Benoit Bilanges, Samira Alliouachene, Wayne Pearce, Daniele Morelli, Gyorgy Szabadkai, Yuen-Li Chung, Gaetan Chicanne, Colin Valet, Julia M. Hill, Peter J. Voshol, Lucy Collinson, Christopher Peddie, Khaled Ali, Essam Ghazaly, Vinothini Rajeeve, Georgios Trichas, Shankar Srinivas, Claire Chaussade, Rachel S. Salamon, Jonathan M. Backer, Cheryl L. Scudamore, Maria A. Whitehead, Erin P. Keaney, Leon O. Murphy, Robert K. Semple, Bernard Payrastre, Sharon A. Tooze, Bart Vanhaesebroeck

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling

Inma M. Berenjeno, Roberto Pineiro, Sandra D. Castillo, Wayne Pearce, Nicholas McGranahan, Sally M. Dewhurst, Valerie Meniel, Nicolai J. Birkbak, Evelyn Lau, Laurent Sansregret, Daniele Morelli, Nnennaya Kanu, Shankar Srinivas, Mariona Graupera, Victoria E. R. Parker, Karen G. Montgomery, Larissa S. Moniz, Cheryl L. Scudamore, Wayne A. Phillips, Robert K. Semple, Alan Clarke, Charles Swanton, Bart Vanhaesebroeck

NATURE COMMUNICATIONS (2017)

Article Immunology

Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis

Adriana Soler, Helena Serra, Wayne Pearce, Ana Angulo, Julie Guillermet-Guibert, Lori S. Friedman, Francesc Vinals, Holger Gerhardt, Oriol Casanovas, Mariona Graupera, Bart Vanhaesebroeck

JOURNAL OF EXPERIMENTAL MEDICINE (2013)

Article Multidisciplinary Sciences

Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer

Khaled Ali, Dalya R. Soond, Roberto Pineiro, Thorsten Hagemann, Wayne Pearce, Ee Lyn Lim, Hicham Bouabe, Cheryl L. Scudamore, Timothy Hancox, Heather Maecker, Lori Friedman, Martin Turner, Klaus Okkenhaug, Bart Vanhaesebroeck

NATURE (2014)

Article Multidisciplinary Sciences

ASK1 promotes the contact hypersensitivity response through IL-17 production

Junya Mizukami, Takehiro Sato, Montserrat Camps, Hong Ji, Thomas Rueckle, Dominique Swinnen, Ryoji Tsuboi, Kohsuke Takeda, Hidenori Ichijo

SCIENTIFIC REPORTS (2014)

Article Immunology

Characterization of novel PI3Kδ inhibitors as potential therapeutics for SLE and lupus nephritis in pre-clinical studies

Philipp Haselmayer, Montserrat Camps, Mathilde Muzerelle, Samer El Bawab, Caroline Waltzinger, Lisa Bruns, Nada Abla, Mark A. Polokoff, Carole Jond-Necand, Marilene Gaudet, Audrey Benoit, Dominique Bertschy Meier, Catherine Martin, Denise Gretener, Maria Stella Lombardi, Roland Grenningloh, Christoph Ladel, Jorgen Soberg Petersen, Pascale Gaillard, Hong Ji

FRONTIERS IN IMMUNOLOGY (2014)

Article Immunology

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models

Philipp Haselmayer, Montserrat Camps, Lesley Liu-Bujalski, Ngan Nguyen, Federica Morandi, Jared Head, Alison O'Mahony, Simone C. Zimmerli, Lisa Bruns, Andrew T. Bender, Patricia Schroeder, Roland Grenningloh

JOURNAL OF IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner

Ralitsa R. Madsen, Rachel G. Knox, Wayne Pearce, Saioa Lopez, Betania Mahler-Araujo, Nicholas McGranahan, Bart Vanhaesebroeck, Robert K. Semple

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Chemistry, Medicinal

Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases

Richard D. Caldwell, Hui Qiu, Ben C. Askew, Andrew T. Bender, Nadia Brugger, Montserrat Camps, Mohanraj Dhanabal, Vikram Dutt, Thomas Eichhorn, Anna S. Gardberg, Andreas Goutopoulos, Roland Grenningloh, Jared Head, Brian Healey, Brian L. Hodous, Bayard R. Huck, Theresa L. Johnson, Christopher Jones, Reinaldo C. Jones, Igor Mochalkin, Federica Morandi, Ngan Nguyen, Michael Meyring, Justin R. Potnick, Dusica Cvetinovic Santos, Ralf Schmidt, Brian Sherer, Adam Shutes, Klaus Urbahns, Ariele Viacava Follis, Ansgar A. Wegener, Simone C. Zimmerli, Lesley Liu-Bujalski

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Multidisciplinary Sciences

Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy

Matt Lechner, Volker H. Schartinger, Christopher D. Steele, Wen Long Nei, Marc Lucas Ooft, Liesa-Marie Schreiber, Christodoulos P. Pipinikas, Grace Tin-Yun Chung, Yuk Yu Chan, Feng Wu, Ka-Fai To, Chi Man Tsang, Wayne Pearce, Daniele Morelli, Martin Philpott, Liam Masterson, Reshma Nibhani, Graham Wells, Christopher G. Bell, Julia Koller, Susanne Delecluse, Yim Ling Yip, Jacklyn Liu, Cillian T. Forde, Martin D. Forster, Amrita Jay, Jozsef Dudas, Annika Krapp, Simon Wan, Christian Uprimny, Susanne Sprung, Johannes Haybaeck, Tim R. Fenton, Kerry Chester, Christina Thirlwell, Gary Royle, Teresa Marafioti, Rajeev Gupta, Sagung Rai Indrasari, Camelia Herdini, Mohd Afiq Mohd Slim, I. Indrawati, Liam Sutton, Renske Fles, Bing Tan, Joe Yeong, Amit Jain, Shuting Han, Haitao Wang, Kelvin S. H. Loke, Wan He, Ruilian Xu, Hongtao Jin, Zhiqiang Cheng, David Howard, Peter H. Hwang, Quynh-Thu Le, Joshua K. Tay, Robert B. West, Sai Wah Tsao, Tim Meyer, Herbert Riechelmann, Udo Oppermann, Henri-Jacques Delecluse, Stefan M. Willems, Melvin L. K. Chua, Pierre Busson, Kwok Wai Lo, Guido Wollmann, Nischalan Pillay, Bart Vanhaesebroeck, Valerie J. Lund

Summary: This study reveals that somatostatin receptor 2 is induced by the Epstein-Barr virus in nasopharyngeal carcinoma and plays a key role in the diagnosis, imaging, targeted therapies, and prognosis of the disease.

NATURE COMMUNICATIONS (2021)

Article Oncology

Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development

Priyanka Tibarewal, Victoria Rathbone, Georgia Constantinou, Wayne Pearce, Mahreen Adil, Zofia Varyova, Lisa Folkes, Alix Hampson, Gala Anastasia Electra Classen, Adriana Alves, Sara Carvalho, Cheryl L. Scudamore, Bart Vanhaesebroeck

Summary: PTEN is an important tumor suppressor gene in cancer, and its deregulation can lead to various cancers. In this study, the authors investigated the potential of the PI3K/mTOR pathway inhibitor rapamycin in preventing cancer in a mouse model of PTEN hamartoma tumor syndrome (PHTS). They found that long-term treatment with low-dose rapamycin significantly improved survival and delayed the development of certain tumors in mice with heterozygous germline Pten loss. This suggests that rapamycin may have cancer prevention potential in human PHTS and other cancers with PI3K pathway activation.

JOURNAL OF PATHOLOGY (2022)

No Data Available